Home/Filings/4/0001214659-17-005694
4//SEC Filing

THOMPSON JOHN CRAIG 4

Accession 0001214659-17-005694

CIK 0001316175other

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 7:14 PM ET

Size

4.7 KB

Accession

0001214659-17-005694

Insider Transaction Report

Form 4
Period: 2017-09-20
THOMPSON JOHN CRAIG
DirectorPresident & CEO
Transactions
  • Purchase

    Common stock

    2017-09-20$1.32/sh+8,550$11,28619,848 total
Footnotes (1)
  • [F1]The Reporting Person acquired the shares in the open market at a cost of $1.32 per share.

Issuer

Anthera Pharmaceuticals Inc

CIK 0001316175

Entity typeother

Related Parties

1
  • filerCIK 0001509643

Filing Metadata

Form type
4
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 7:14 PM ET
Size
4.7 KB